Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BriaCell Therapeutics Corp.BCTX · Entity 7454 | Director · Chairman | December 28, 2022 | December 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BriaCell Therapeutics Corp.
Report date December 28, 2022 · Filed December 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 169,856 |
Reported balance
After 2022-12-28 transaction · row 1
1 source rowRow 1 · 2022-12-28 · Purchase · Acquired 28,000 · Balance 169,856 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 28, 2022 Filed Dec 28, 2022 21:38 UTC | BriaCell Therapeutics Corp. BCTX · Entity 7454 | PurchaseCommon Shares | 28,000 | $4.58 | $128,240.00 |
DisclosureSEC source: 0001493152-22-036669 · ownership.xml · nonDerivative · entry 1 Bondarenko Jamieson · CIK 0001942516 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,856 Read SEC document |
| December 20, 2022 Filed Dec 21, 2022 02:02 UTC | BriaCell Therapeutics Corp. BCTX · Entity 7454 | PurchaseCommon Shares | 22,000 | $5.35 | $117,700.00 |
DisclosureSEC source: 0001493152-22-036060 · ownership.xml · nonDerivative · entry 1 Bondarenko Jamieson · CIK 0001942516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,856 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.